例句與造句

1. The progression of neurological manifestations of cobalamin deficiency is generally gradual.
2. Neurological manifestations can include tremors, periodic paralysis.
3. There have been several hypotheses about the role of copper and some of its neurological manifestations.
4. Vitamin D deficiency was found to be related to neurological manifestations and the presence of lymphoma among patients.
5. One of the major concerns following acute carbon monoxide poisoning is the severe delayed neurological manifestations that may occur.
6. It's difficult to find neurological manifestation in a sentence. 用neurological manifestation造句挺難的
7. This fever is a several illness with hemorrhagic and neurological manifestations and a case fatality of fifteen to thirty percent.
8. This causes elevations in GHB and is believed to be the trademark of this disorder and cause for the neurological manifestations seen.
9. The neurological manifestations of BYS were first described by Yoshinari et al . including patients with peripheral neuritis, meningitis and cranial neuritis ( facial nerve palsy, diplopia and deafness ).
10. MAPK8IP2 appears to regulate the ratio of AMPA receptors to NMDA receptors at glutamate synapses, and thus may be an important contributor to the intellectual dysfunction and related neurological manifestations characteristic of PMS.
11. The clinical presentation of TMA, although dependent on the type, typically includes : fever, microangiopathic hemolytic anemia ( see schistocytes in a blood smear ), renal failure, thrombocytopenia, neurological manifestations.
12. The " pulseless phase " is characterized by vascular insufficiency from intimal narrowing of the vessels manifesting as arm or leg claudication, renal artery stenosis causing hypertension, and neurological manifestations due to decreased blood flow to the brain.
13. Bacterial overgrowth and B12 deficiency ( pernicious anemia ) can cause micronutrient deficiencies that result in various clinical neurological manifestations, including visual changes, paresthesias, ataxia, limb weakness, gait disturbance, memory defects, hallucinations and personality and mood changes.
14. For the future however, treatment strategies should focus on both decreasing the total production of GHB and increasing the total concentration of GABA and further assessing whether the effects of these changes influences the neurological manifestations seen in patients afflicted with SSADH deficiency.
15. Elevations of GHB have been shown to induce spike and wave activity similar to that seen in generalized absence epilepsy in animal models as well, which has motivated researchers to increase their knowledge on the relationship between GHB and the neurological manifestations seen in SSADH deficiency.
16. In January 2009, Actelion announced the drug miglustat ( Zavesca ) had been approved in the European Union for the treatment of progressive neurological manifestations in adult patients and pediatric patients with NPC . The drug is available to patients in the United States on an experimental basis.